Top Markets
#1 MowCat MowCat +26.72%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.90%
#3 Versatize Coin Versatize Coin +16.67%
#4 QuantixAI QuantixAI +15.74%
#5 OriginTrail OriginTrail +12.28%
#6 Pons Pons +11.65%
#7 Wrapped NXM Wrapped NXM +10.43%
#8 Collector Crypt Collector Crypt +9.04%
#9 StonkBroker StonkBroker +8.80%
#10 Siren Siren +8.07%
Coin of the day
MowCat MowCat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Rang in aandelen #20756
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Aandeelprijs
$2.32
Marktkapitalisatie
$122.09M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
109.59%
Land
TW
Handel Great Novel Therapeutics Biotech & Medicals (7427)

Categorie

Healthcare
Winst voor Great Novel Therapeutics Biotech & Medicals (7427)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Great Novel Therapeutics Biotech & Medicals bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Great Novel Therapeutics Biotech & Medicals van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH